Gene · 910
Papers2,023
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,023
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multitargeted Virtual Screening and Molecular Simulation of Natural Product-like Compounds against GSK3β, NMDA-Receptor, and BACE-1 for the Management of Alzheimer's Disease. | Pharmaceuticals (Basel) | 2023 | 37111379 | PubTator, text mining | PubMed |
| Structural analysis of cancer-relevant TCR-CD3 and peptide-MHC complexes by cryoEM. | Nat Commun | 2023 | 37100770 | PubTator, text mining | PubMed |
| Fist Detection of Hb Suqian[β42(CD1) Phe→Leu, HBB:c.129T > A] in Han Chinese. | Hemoglobin | 2023 | 37092366 | PubTator, text mining | PubMed |
| Detection of anti-ganglioside antibodies in Guillain-Barré syndrome. | Ann Transl Med | 2023 | 37090048 | PubTator, text mining | PubMed |
| Blocking activation of CD4-CD8- T cells modulates their cytotoxic potential and decreases the expression of inflammatory and chemotactic receptors. | Clin Immunol | 2023 | 37088297 | PubTator, text mining | PubMed |
| Epigenetic control of CD1D expression as a mechanism of resistance to immune checkpoint therapy in poorly immunogenic melanomas. | Front Immunol | 2023 | 37077920 | PubTator, text mining | PubMed |
| Inhibition of PANX1 Channels Reduces the Malignant Properties of Human High-Risk Neuroblastoma. | J Cancer | 2023 | 37056395 | PubTator, text mining | PubMed |
| Assessment of the Anticancer Effect of Chlorojanerin Isolated from Centaurothamnus maximus on A549 Lung Cancer Cells. | Molecules | 2023 | 37049823 | PubTator, text mining | PubMed |
| Lysine Deacetylase Substrate Selectivity: Distinct Interaction Surfaces Drive Positive and Negative Selection for Residues Following Acetyllysine. | Biochemistry | 2023 | 37043688 | PubTator, text mining | PubMed |
| Molecular landscape and emerging therapeutic strategies in breast cancer brain metastasis. | Ther Adv Med Oncol | 2023 | 37034479 | PubTator, text mining | PubMed |
| Mucosal-associated invariant T cells in hematological malignancies: Current knowledge, pending questions. | Front Immunol | 2023 | 37020559 | PubTator, text mining | PubMed |
| Role of MHC class I pathways in Mycobacterium tuberculosis antigen presentation. | Front Cell Infect Microbiol | 2023 | 37009503 | PubTator, text mining | PubMed |
| UcTCRdb: An unconventional T cell receptor sequence database with online analysis functions. | Front Immunol | 2023 | 36993970 | PubTator, text mining | PubMed |
| Anti-Obesity and Anti-Inflammatory Effects of Novel Carvacrol Derivatives on 3T3-L1 and WJ-MSCs Cells. | Pharmaceuticals (Basel) | 2023 | 36986440 | PubTator, text mining | PubMed |
| Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells. | JCI Insight | 2023 | 36976644 | PubTator, text mining | PubMed |
| Modulating the Kynurenine pathway or sequestering toxic 3-hydroxykynurenine protects the retina from light-induced damage in Drosophila. | PLoS Genet | 2023 | 36952572 | PubTator, text mining | PubMed |
| Structural variation cooperates with permissive chromatin to control enhancer hijacking-mediated oncogenic transcription. | Blood | 2023 | 36947815 | PubTator, text mining | PubMed |
| Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma. | Cancer Res | 2023 | 36934744 | PubTator, text mining | PubMed |
| Exhausted intratumoral Vδ2- γδ T cells in human kidney cancer retain effector function. | Nat Immunol | 2023 | 36928415 | PubTator, text mining | PubMed |
| Recent advances in graft-versus-host disease. | Fac Rev | 2023 | 36923700 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/910/papers?page=8